29.00
29.00 (0%)
As of Feb 14, 2025
Zai Lab Ltd [ZLAB]
Source:
Company Overview
Zai Lab Ltd is a patient-focused, innovative, commercial-stage, global biopharmaceutical company with a substantial presence in both Greater China and the United States. We are focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease.
| Country | United States |
| Headquarters | cambridge, massachusetts |
| Phone Number | 857 706 2604 |
| Industry | manufacturing |
| CEO | Samantha (Ying) Du |
| Website | www.zailaboratory.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $399 |
| Operating Profit | $-282.1 |
| Net Income | $-257.1 |
| Net Cash | $-240.5 |
Profit Ratios
| Gross Margin | $546.8 |
| Operating Margin | -70.7 |
| Profit as % of Revenues | -212.7% |
| Profit as % of Assets | -23.1% |
| Profit as % of Stockholder Equity | -30.6% |
Management Effectiveness
| Return on Equity | -30.6% |
| Return on Assets | -21.7% |
| Turnover Ratio | 35.9% |
| EBITA | $-282.1 |
Balance Sheet and Cash Flow Measures
| Total Assets | $1,185.8 |
| Total Liabilities | $344.9 |
| Operating Cash Flow | $-214.9 |
| Investing Cash Flow | $-375.2 |
| Financing Cash Flow | $349.9 |
